An innovative study, co-designed by Aboriginal Women, has led to remission of type 2 diabetes. The research described and ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

Along the way, the Lexington teen crossed paths not only with Kendrick Lamar, but also Jay-Z, Samuel L. Jackson and Serena Williams.

Byram Healthcare, a leader in home-based care and part of the Owens & Minor (NYSE: OMI) family, recently launched ...

This CGM will track your body's response - Could personalised glucose data inform your body’s metabolism and performance?

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...

Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

Devices and Getinge have recently announced their partnership under which they will integrate Getinge’s bioreactors with 908 ...